Year |
Citation |
Score |
2020 |
Godfrey S, Rorie C. Abstract A08: Cadmium elicits a differential cytotoxic response in triple-negative breast cancer cells Cancer Prevention Research. 13. DOI: 10.1158/1940-6215.Envcaprev19-A08 |
0.479 |
|
2020 |
Godfrey S, Rorie C. Abstract B072: Cadmium elicits a differential cytotoxic response in triple-negative breast cancer cells Cancer Epidemiology, Biomarkers & Prevention. DOI: 10.1158/1538-7755.Disp18-B072 |
0.443 |
|
2017 |
Rorie CJ, Moses MM, Musa MK, Godfrey SS. Abstract 5879: Establishing doxorubicin resistant HCC1806 triple negative breast cancer cell lines result in the differential expression of let7a and miR34a Cancer Research. 77: 5879-5879. DOI: 10.1158/1538-7445.Am2017-5879 |
0.505 |
|
2016 |
Baines AT, Martin PM, Rorie CJ. Current and Emerging Targeting Strategies for Treatment of Pancreatic Cancer. Progress in Molecular Biology and Translational Science. 144: 277-320. PMID 27865460 DOI: 10.1016/Bs.Pmbts.2016.09.006 |
0.33 |
|
2016 |
Moses MM, Godfrey SS, Lusk NQ, Rorie CJ. Abstract 83: MicroRNAs associated with the p53 tumor suppressor signaling network are differentially expressed in triple negative breast cancer cell lines Cancer Research. 76: 83-83. DOI: 10.1158/1538-7445.Am2016-83 |
0.497 |
|
2014 |
Rorie CJ, Arrington BL, Godfrey SS, McCoy AS, Gurley KM. Abstract 1472: The differential expression of miRNAs in breast cancer cell lines Cancer Research. 74: 1472-1472. DOI: 10.1158/1538-7445.Am2014-1472 |
0.47 |
|
2013 |
Rorie CJ, Richardson SL, Lucas AC, Thomas PA, Gurley KM, Franks MA. Abstract 604: Styrene compounds induce apoptosis in triple negative breast cancer cell lines. Cancer Research. 73: 604-604. DOI: 10.1158/1538-7445.Am2013-604 |
0.476 |
|
2012 |
Rorie CJ, King J, Bryant R, Gurley K. Abstract 4908: The apoptotic response of the triple negative breast cancer cell line HCC1806 to chemotherapeutics Cancer Research. 72: 4908-4908. DOI: 10.1158/1538-7445.Am2012-4908 |
0.52 |
|
2011 |
King JL, Gurley KM, Rorie CJ. Abstract 2141: The differential apoptotic responses of normal breast cells versus luminal and triple negative breast cancer cells to chemotherapeutic agents Cancer Research. 71: 2141-2141. DOI: 10.1158/1538-7445.Am2011-2141 |
0.523 |
|
2006 |
Saxena A, Rorie CJ, Dimitrova D, Daniely Y, Borowiec JA. Nucleolin inhibits Hdm2 by multiple pathways leading to p53 stabilization. Oncogene. 25: 7274-88. PMID 16751805 DOI: 10.1038/Sj.Onc.1209714 |
0.394 |
|
2004 |
Rorie CJ, Weissman BE. The Ews/Fli-1 fusion gene changes the status of p53 in neuroblastoma tumor cell lines. Cancer Research. 64: 7288-95. PMID 15492248 DOI: 10.1158/0008-5472.Can-04-1610 |
0.628 |
|
2004 |
Rorie CJ, Thomas VD, Chen P, Pierce HH, O'Bryan JP, Weissman BE. The Ews/Fli-1 fusion gene switches the differentiation program of neuroblastomas to Ewing sarcoma/peripheral primitive neuroectodermal tumors. Cancer Research. 64: 1266-77. PMID 14973077 DOI: 10.1158/0008-5472.Can-03-3274 |
0.508 |
|
2001 |
Decristofaro MF, Betz BL, Rorie CJ, Reisman DN, Wang W, Weissman BE. Characterization of SWI/SNF protein expression in human breast cancer cell lines and other malignancies. Journal of Cellular Physiology. 186: 136-45. PMID 11147808 DOI: 10.1002/1097-4652(200101)186:1<136::Aid-Jcp1010>3.0.Co;2-4 |
0.615 |
|
Show low-probability matches. |